Clinical Trial: Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282145) titled 'Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers' on Nov. 17.

Brief Summary: A randomized, double-blinded, single/multiple dosing, dose escalation Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetic characteristics of BCD101 in healthy adult volunteers.

The primary objectives of this study are to determine:

1. The safety and tolerability of BCD101 in healthy adult volunteers.

2. The pharmacokinetic profile of BCD101 following single and multiple dosing.

A control group is included, and dose cohorts will be compared to assess dose-dependent differences in safety, tolerability, and pha...